Air Jordan Caps
The next BioVaria, featuring the biennial Spin off Panel, will take place on 11 May 2015 in Munich.
'The technologies presented perfectly matched the participants' inlicensing needs,' Dr Christian Stein, CEO of Ascenion comments. 'There are many more high potential partners in Eastern Europe and other European regions that have so far received little recognition. For 2015, we will work to attract as many of them as possible as BioVaria partners.'
'There are two things that make BioVaria stand out from the Adidas Cap Camo
7th BioVaria Attracts Leading Life Science Inn
9 May 2014, Munich, Germany On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scientists and technology transfer professionals to learn about the hottest life science innovations from universities and research institutes across Europe and initiate co development partnerships. Altogether, 140 participants joined the event.
Interactive, efficient one day format combining 10 min oral presentations with an all day poster exhibition.
to face with the inventors.
Presentation of licensable technologies originating from a broad range of research institutes and universities across Europe. Nike Cap Images
Ample space to discuss scientific details face Adidas Cap Red
The conference, organized by Ascenion and ten further technology transfer organizations, featured a total of 40 licensing opportunities: diagnostic and therapeutic projects as well as platform technologies. New partners such as IOCB TTO from Prague, Czech Republic, gave new impulses that were well received from industry.
Four industry leaders, Bayer Pharma, Boehringer Ingelheim, Johnson Johnson Innovation and MSD, also presented their inlicensing needs.
crowd of partnering events: the breadth and quality of the technologies presented and the interactive and familiar atmosphere,' said Dr Heinz Schwer, Senior Director Corporate Finance Corporate Development at MorphoSys.
Key features of BioVaria 2014:
Unique gathering of Europe's top scientists, technology transfer professionals and industry representatives.
Ascenion GmbH is an IP asset management company with particular expertise in the life sciences. Ascenion advises and supports public research institutions with regard to the protection and exploitation of their intellectual property (patents, know how, materials), and initiates and mediates license agreements between research institutions and industry. The company places particular emphasis on coaching company founders and on active equity management. Ascenion was founded in 2001 as a 100% subsidiary of the LifeScience Foundation for the Promotion of Science and Research and has since acquired 23 Air Jordan Caps research institutes in the Helmholtz and Leibniz Associations, together with the Charit, the Hannover Medical School, the Universitt zu Lbeck and the research institute TWINCORE as partners. Ascenion currently markets around 750 technologies on behalf of these institutes, and closes an average of about 80 revenue generating agreements between research and industry per year. The team has also coached numerous spin offs through their foundation and early growth and Ascenion holds equity in 24 of these companies. Ascenion's headquarters are in Munich, with further offices in Berlin, Braunschweig, Hamburg, Hanover and Neuherberg.
Air Jordan Caps
Fred Perry Womens Bomber JacketHome / Air Jordan Caps
Cheap Custom Embroidered Polo Shirts No Minimum
Arizona Diamondbacks Hat Purple
New Era Colorado Avalanche
Polo Shirts Buy Online India
Cleveland Indians Hat
New Era Canada Hockey
Xxl Polo T Shirts Online India
New Era Ny Giants Hat
Nike Hats Womens
Jordan Cap Collection
Wholesale Polo Shirts Downtown Los Angeles
Chicago Cubs Hat 47
Jordan Hats Snapback
Nike Hats Caps